Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Jörg Liebmann, PhD
joergli@miltenyi.com


Study Location:

Skip to Main Content

Keep up to date

Sign up for news and information about taking part and shaping research.

English | Cymraeg
Be Part of Research - Trial Details - Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis

Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis

Recruiting

Open to: All Genders

Age: 18 Years - 45 Years

Medical Conditions

Preeclampsia


This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.


This clinical investigation is a medical device trial to examine the safety and efficacy of TheraSorb sFlt-1 adsorber treatment of pregnant patients with preeclampsia.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Sep 2016 Dec 2024

Interventional

Intervention Type : Device
Intervention Description : Removal of excessive sFlt-1 from the plasma of subjects/ patients with therapeutic apheresis.

Intervention Arm Group : Phase 0 - healthy volunteers;Phase A - preeclampsia patients;Phase B - preeclampsia patients



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Cambridge Clinical Trials Unit, Addenbrooke's Hospital
    Cambridge
    CB2 0QQ
  • Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital
    Oxford
    OX3 9DU

Jörg Liebmann, PhD
joergli@miltenyi.com



The study is sponsored by Miltenyi Biomedicine GmbH and funded by Cromsource.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: NCT02923206
Last updated 05 December 2023

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.